Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome
Condition(s):Nephrotic SyndromeLast Updated:July 29, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Nephrotic SyndromeLast Updated:July 29, 2020Terminated
Condition(s):Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell LymphomaLast Updated:July 30, 2014Terminated
Condition(s):Multiple Sclerosis (MS)Last Updated:March 22, 2024Recruiting
Condition(s):Relapsing Remitting Multiple SclerosisLast Updated:February 7, 2022Unknown status
Condition(s):Leukaemia, Lymphocytic, ChronicLast Updated:November 13, 2017Completed
Condition(s):Chronic Lymphocytic Leukemia (CLL)Last Updated:July 20, 2011Withdrawn
Condition(s):Multiple Sclerosis; Tomography, Optical Coherence; Retinal Degeneration; Visual AcuityLast Updated:December 12, 2023Enrolling by invitation
Condition(s):Chronic Lymphocytic Leukemia (CLL)Last Updated:July 20, 2011Terminated
Condition(s):Relapsing Multiple SclerosisLast Updated:February 6, 2024Active, not recruiting
Condition(s):Waldenstrom MacroglobulinaemiaLast Updated:May 30, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.